The gut microbiota contributes to the pathophysiology of non-alcoholic fatty liver disease
(NAFLD). Histidine is a key energy source for the microbiota, scavenging it from the host. Its …

Emerging evidence indicates that alteration of gut microbiota plays an important role in
chronic kidney disease (CKD)-related vascular calcification (VC). We aimed to investigate …

Nonalcoholic fatty liver disease (NAFLD) particularly affects patients with type 2 diabetes
and obesity. The incidence of NAFLD has increased significantly over the last decades and …

Background/Aims Shifts in the gut microbiota and metabolites are interrelated with liver
cirrhosis progression and complications. However, causal relationships have not been …

Metabolic dysfunction‐associated fatty liver disease (MAFLD) is a complex disease
involving alterations in multiple biological processes regulated by the interactions between …

The gut microbiota is a complex ecosystem that has coevolved with the human body for
hundreds of millions of years. In the past 30 years, with the progress of gene sequencing …

Currently, there is evidence that alteration in the gut ecosystem contributes to the
development of liver diseases, however, the complex mechanisms involved are still unclear …

The gut is a selective barrier that not only allows the translocation of nutrients from food, but
also microbe-derived metabolites to the systemic circulation that flows through the liver …

Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is the most
common cause of liver disease. Increasing evidence indicates that the gut microbiota can …

The dysbiosis of oral microbiota is linked to numerous diseases and is associated with
personal lifestyles, such as alcohol drinking. However, there is inadequate data to study the …